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Abstract People who visit high-altitude areas are ex-
posed to a stressful environment and a good percentage of
them suffer from high-altitude-induced diseases, includ-
ing systemic hypertension. Identification of genetic
markers for high-altitude-induced diseases would help
to reduce the rate of morbidity/mortality from such
diseases. The development of systemic hypertension on
exposure to high altitude (3,500 m) for 30 days in
otherwise normotensive natives of low-altitudes was
investigated. The angiotensin-converting enzyme (ACE)
insertion/deletion (I/D) genotypes and renin-angiotensin-
aldosterone system were simultaneously studied. In the
hypertensives during their stay at high altitude, the ACE
D allele frequency was significantly higher than in the
normotensives (0.67 versus 0.32 c21 = 10.6, P < 0.05). In
the normotensives during their stay at high altitude, there
was no significant increase in plasma aldosterone levels
despite increased plasma renin activity. Results of the
present study suggest that environmental changes and pre-
existing genetic factors, namely the ACE D allele, might
be two of the factors predisposing natives of low altitudes
to systemic hypertension, a polygenic disease, at high
altitude.
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Introduction
High-altitude environments, those at a height of more
than 3,000 m, imply stress factors such as hypoxia, cold,
humidity, solar radiation, cosmic radiation and isolation.
High-altitude exposure causes many physiological and
biochemical changes in man. It has been reported that
increased sympathetic stimulation and autonomic activity
contribute to a rise in systemic blood pressure at high
altitude (Malhotra et al. 1976; Wolfel et al. 1994).
Ongoing research on hypertension has established that
the renin-angiotensin-aldosterone system, the primary
regulator of plasma Na+ and re-absorption by the kidney,
plays an important role in the pathogenesis of hyperten-
sion. Molecular studies of hypertension concentrating on
the renin-angiotensin-aldosterone system have identified
a number of polymorphic proteins in this system with
their corresponding genetic loci. Angiotensin I is con-
verted to angiotensin II by the angiotensin-converting
enzyme (ACE). Angiotensin II is a potent vasoconstrictor,
regulating blood pressure and, hence, a causative factor
for systemic hypertension. There are two alleles in the
ACE gene locus, one with a deletion (D) and other with
an insertion (I) of 287 base pairs within intron 16. The
association of the ACE D allele with systemic hyperten-
sion has been shown (Mastana and Nunn 1997; Shen et al.
1998; Nakano et al. 1998).
A large number of people are exposed to the stressful
environment of high altitude during visits for a variety of
reasons: tourism, mountaineering and in the course of
their occupation; the last category includes troops guard-
ing the borders. The aim of the present study was to test
whether ACE gene I/D polymorphism can be used as a
genetic marker to identify soldiers who are potentially at
risk of developing high-altitude-induced systemic hyper-
tension.
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Materials and methods
The study population consisted of 46 age-matched healthy normal
male volunteers who had never been to high altitude. Informed
written consent was obtained from all the volunteers participating
in the study. None was taking any medication for blood pressure.
All the volunteers were examined initially at plains. Their age,
height and weight were 23.8 € 0.6 years, 169.6 € 0.8 cm and 59.3 €
0.9 kg respectively. The body mass index (BMI) of the volunteers
was calculated [body weight/height2 (kg/m2)]. Oxygen saturation of
the blood (SaO2) was measured using a Pulse 503 Oximeter,
Criticare Systems Inc. USA. Blood pressure and pulse rate of all the
subjects were measured in the morning between 0800 and 0900
hours by an automatic blood pressure monitor (model OSIM 0505
from OSIM International, Singapore). SaO2, pulse rate, systolic
blood pressure (SBP) and diastolic blood pressure (DBP) values
recorded were the means of three readings taken at least 2 min
apart. On the basis of blood pressures recorded, potential subjects
were classified as normotensive (blood pressure  140/90 mm Hg,
18.6/12 kPa) or hypertensives (blood pressure  140/90 mm Hg,
18.6/12 kPa) according to the International Society of Hypertension
Guidelines Subcommittee (1999). All the 46 volunteers were
normotensives at plains. Blood samples of the volunteers were
collected and heparinised blood was used to analyze the plasma
levels of ACE, renin activity and aldosterone. For ACE genotype
investigation blood samples with ACD anticoagulant (trisodium
citrate 22.0 g/l, citric acid 8.0 g/l, and dextrose 24.5 g/l) were used.
Serum was used for electrolyte (Na+, K+) analysis; 24 h urine
samples were collected for volume measurement and electrolyte
(Na+, K+) analysis.
After the initial examination at plains, all the volunteers were
transported to high altitude (3,500 m) by air. On arrival at high
altitude the volunteers were examined on days 1 (HA D01), 10 (HA
D10) and 30 (HA D30) of their stay. After 30 days stay at high
altitude all the volunteers were returned to the plains by air. On the
7th (DI 07) and 14th (DI 14) days after their return to the plains, the
volunteers were re-examined. The parameters studied at high
altitude on days 1, 10 and 30 as well as on days 7th and 14th day
after their return were similar to those used in the initial
examination of the subjects, namely BMI, pulse rate, SaO2, SBP,
DBP, plasma ACE, plasma renin activity (PRA), aldosterone,
serum electrolytes, 24-h urine volume, urine electrolyte (Na+, K+)
levels, and ACE I/D genotypes. On the basis of blood pressures
recorded during their high-altitude stay the volunteers were
classified as normotensive or hypertensive (International Society
of Hypertension Guidelines Subcommittee 1999).
Determination of biochemical parameters
Plasma angiotensin-converting enzyme (ACE) activity was mea-
sured by using diagnostic kits obtained from Sigma Diagnostics (P.
O. box 14508 St. Louis, USA). Plasma renin activity and
aldosterone levels were measured by radio-immunoassay kits
obtained from Immunotech (A. Coulter Company, Marseille Cedex,
France). Plasma and urinary electrolyte (Na+, K+) levels were
measured by an AVL 988-3 electrolyte analyzer.
Genotype investigation
Genomic DNA was isolated from the peripheral blood leukocytes
by a salting-out procedure (Miller et al. 1988). The polymerase
chain reaction (PCR) was used for amplification of the ACE gene.
The primer sequence used for the sense strand oligonucleotide was
50-CTG GAG ACC ACT CCC ATCCTT TCT-30 and for the
antisense oligo nucleotide 50-GAT GTG GCC ATC ACA TTC
GTC AGAT-30 (Rigat et al. 1992). The PCR conditions and
thermocycling procedure, performed with a Gene Amp PCR
system, consisted of initial denaturation at 94 C for 4 min
followed by 30 cycles of denaturation at 94 C for 1 min, annealing
at 58 C for 1 min and extension at 72 C for 2 min, and a final
extension at 74 C for 7 min (Rigat et al. 1992). The PCR-amplified
products were resolved on 2.0% agarose gel and detected by
ethidium bromide for identification of ACE I/D polymorphism (a
190-bp fragment in the case of deletion and a 490-bp fragment in
the presence of an insertion of the 287-bp alu sequence) as
suggested by Rigat et al. (1992).
Statistical analysis
Results of BMI, blood pressure, SaO2, plasma ACE, PRA,
aldosterone, serum electrolytes, urine volume and urine electrolytes
were expressed as means € SE. The statistical significance of these
parameters between two groups was assessed by one-way analysis
of variance. Frequencies of the ACE gene allele were deduced from
genotype frequencies and the differences between groups were
tested by c2-test. A value of P less than 0.05 was considered to be
statistically significant.
Results
The results for BMI, blood pressures, pulse rate and SaO2
changes of all the subjects have been given in Table 1.
Out of 46 volunteers 28 were normotensive and 18
hypertensive at high altitude. At high altitude no signif-
icant change in BMI of the normotensive volunteers was
observed but the BMI of hypertensive volunteers at high
altitude showed significant increases in comparison to the
responses of normotensives of the respective groups. In
volunteers suffering from systemic hypertension there
was a significant increase in both SBP and DBP (140/
90 mm Hg) during their stay at high altitude in
comparison to baseline values. In normotensive volun-
teers a significant increase in pulse rate was observed on
the 30th day at high altitude but the pulse rate of
hypertensives was significantly high during their whole
30 days at high altitude and on the 7th day after their
return to plains. In normotensive and hypertensive
subjects, the decrease in SaO2 during the stay at high
altitude was similar but significant in comparison to
baseline values (Table 1).
Changes observed in plasma ACE, PRA, aldosterone,
sodium and potassium values of volunteers during their
stay at high altitude and on return to the plains, in
comparison to baseline values, are given in Table 2. On
the 1st day the volunteers arrived at high altitude, the
plasma ACE values increased significantly in both
normotensives and hypertensives. After the peak rise on
the 1st day at high altitude, the plasma ACE values
gradually declined. On return to the plains, ACE values of
all the volunteers returned to baseline values.
The PRA levels showed a continuous rise during the
stay at high altitude in both normotensive and hyperten-
sive volunteers in comparison to their respective baseline
values. The increase was significant on days 10 and 30 at
high altitude and on day 7 after the return in both the
groups, but in hypertensive volunteers there was also a
significant increase in PRA on the 14th day after
returning to the plains (Table 2). There was no increase
in plasma aldosterone levels during the high-altitude stay
in normotensives volunteers, but in the hypertensive
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volunteers there was a significant rise in plasma aldo-
sterone levels on days 10 and 30 of the stay at high
altitude (Table 2). In normotensive volunteers plasma
sodium levels decreased significantly on days 10 and 30
of their stay at high altitude in comparison to their
baseline values. By contrast, in hypertensive volunteers,
plasma sodium levels increased significantly at high
altitude on days 10 and 30 (Table 2). In normotensive
volunteers plasma potassium levels remained unaltered at
high altitude and on their returns, but in hypertensive
volunteers the plasma potassium levels significantly
increased during the whole duration of their stay at high
altitude in comparison to baseline values (Table 2).
Results on the urine volume excreted in 24 h by both
the normotensive and hypertensive volunteers, and urine
electrolyte levels at high altitude have been given in
Table 3. In normotensive volunteers, during their whole
period of stay at high altitude and on the 7th day after
returning to the plains, there was a significant increase in
the 24-h urine volume excreted in comparison to baseline
values. In hypertensive volunteers the 24-h urine volume
remained unaltered at high altitude and on their return to
the plains (Table 3). Urinary sodium levels increased
significantly in both normotensive and hypertensive
volunteers, during their stay at high altitude and on
returning to the plains (Table 3).
The frequencies of the ACE insertion (I) and deletion
(D) allele in normotensive and hypertensive volunteers at
high altitude are given in Table 4. The D allele frequency
was significantly higher in volunteers who were hyper-
tensive at high altitude.
Discussion
Increase in body weight and obesity have been shown to
be positively associated with blood pressure (Gerber et al.
1998). In the present age-matched study also the volun-
teers who developed systemic hypertension at high
altitude showed an increase in BMI, unlike the normoten-
sives. This indicated that people with higher body weight
are more likely to develop systemic hypertension at high
altitude.
On exposure to high altitude, systemic hypertension
results from sympathetic stimulation and it may continue
for several weeks in non-acclimatized subjects (Malhotra
et al. 1976; Wolfel et al. 1994). In the present study the
volunteers who developed systemic hypertension on
exposure to high altitude also showed an increase in
SBP and DBP during their stay at high altitude. It is
reported that on initially exposure to high altitude stroke
volume is depressed and an increased heart rate partially
compensates for this (Hoon et al. 1977). The observed
increase in pulse rate of volunteers exposed to high
altitude is in agreement with the previous findings. At
high altitude the reduced oxygen pressure limits its
diffusion from the alveoli into the blood, resulting in
decreased blood oxygen saturation. Similar findings of
decreased SaO2 in volunteers taken to high altitude were
observed in the present study.
The involvement of the renin-angiotensin-aldosterone
system in the control of the salt and water balance, and
thereby blood pressure, is well known during hypoxia and
high-altitude exposure (Keynes et al. 1982; Sutton et al.
1977). At high altitude renal renin secretion is stimulated
by decreased renal blood flow (Pauli et al. 1968), which
in turn activates the renin-angiotensin-aldosterone system.
In the present study also the volunteers, on induction to
high altitude showed, a significant rise in PRA on the 10th
and 30th days of their stay at altitude as well as on the 7th
day of after their return to the plains. The level of the rise
was similar in both normotensives and hypertensives. We
also observed a sharp and significant rise in plasma ACE
levels of the volunteers on the first day at high altitude.
Afterwards, on the 10th and 30th days of their stay at high
altitude, though there were increases in plasma ACE
Table 3 Effect of high altitude on 24-hour urine volume and urine electrolytes. Values are means € SEM; Numbers of subjects are shown
in parentheses
Days Normotensive (28) Hypertensive (18)
24-h urine volume
(ml/24 h)
Urine electrolytes 24-h urine volume
(ml/24 h)
Urine electrolytes
Na+(mmol/l) K+ (mmol/l) Na+ (mmol/l) K+ (mmol/l)
Baseline 1387.6 € 72.8 130.9 € 5.2 34.1 € 2.1 1401.3 € 109.9 136.9 € 9.0 35.5 € 2.8
HA D01 1665.9 € 88.2* 153.9 € 6.8* 30.8 € 1.1 1590.0 € 82.8 165.1 € 12.6* 31.7 € 2.5
HA D10 1610.5 € 87.1* 165.8 € 9.2* 30.1 € 1.7 1539.4 € 121.1 170.0 € 16.2* 29.6 € 2.0
HA D30 1724.4 € 84.2* 197.7 € 11.6* 35.2 € 1.6 1587.5 € 110.1 192.4 € 21.1* 33.5 € 2.8
DI D07 1727.2 € 86.7* 170.2 € 7.4* 30.9 € 1.6 1591.9 € 94.6 171.2 € 15.8* 29.2 € 2.5
DI D14 1491.8 € 83.5 158.4 € 5.3* 33.8 € 1.6 1347.1 € 95.9 150.1 € 8.6 28.7 € 3.2
*=Significant in comparison to baseline at P < 0.05
Table 4 ACE insertion (I) and deletion (D) allele frequencies in
volunteers normotensive and hypertensive at high altitude. Num-
bers of subjects are shown in parentheses
Parameters Normotensive (28) Hypertensive (18)
I allele frequency 0.68 0.33
D allele frequency 0.32 0.67
c21 = 10.6, P < 0.05
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levels these were not significant because of large inter-
individual variations in the values.
In the volunteers normotensive at high altitude there
was no change in plasma aldosterone levels despite the
observed rises in their plasma ACE and PRA values. This
showed a dissociation of the renin-angiotensin-aldoster-
one system in volunteers normotensive at high altitude. In
these volunteers at high altitude an unchanged aldosterone
level resulted in a significantly increased 24-h urine
volume with an increased urinary sodium excretion. This
was reflected in decreased plasma sodium levels during
their stay at high altitude. Perhaps the observed diuresis
and other biochemical changes resulted in these volun-
teers acclimatising better and prevented them from
developing systemic hypertension.
In the volunteers hypertensive at high altitude there
was a significant increase in plasma aldosterone and PRA
levels on the 10th and 30th days of their stay at high
altitude. The plasma ACE values were significantly high
on the first day of their arrival at high altitude. This
showed that there was no dissociation of the renin-
angiotensin-aldosterone system in volunteers developing
systemic hypertension at high altitude. In these hyperten-
sive volunteers increased aldosterone levels, as expected,
resulted into no significant increase in 24-h urine volume
at high altitude or on their return, with increased plasma
sodium levels during their stay at high altitude despite an
increased urinary sodium excretion.
A substantial fraction of human blood pressure vari-
ation is genetically determined (Lifton 1996). It is
hypothesized that hypertension-susceptibility genes oper-
ate only in a specific environment (Corvol et al. 1997). In
the present study the frequency of the ACE D allele was
observed to be significantly higher in volunteers who
developed systemic hypertension during their stay at high
altitude. This indicated a positive correlation of the ACE
D allele with high-altitude-induced systemic hyperten-
sion. In our earlier study no significant association of the
ACE D allele was observed with systemic hypertension in
various Indian populations (Gorkha, Sikh, Assamese,
Dogras, Jats, Kumaonis and Yadavas) when studied at
plains (Kumar et al. 2001). The results of the present
study suggest that interaction between the genes and the
environment plays an important role in the development
of systemic hypertension at high altitude. It is likely that
environmental changes and the exposure of pre-existing
genetic factors, namely the ACE D allele (not expressed
fully in the previous environment), predispose a popula-
tion to elevated blood pressure.
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